China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) 5-Year EBITDA Growth Rate : -8.20% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co 5-Year EBITDA Growth Rate?

China Resources Boya Bio-pharmaceutical Group Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.35.

During the past 12 months, China Resources Boya Bio-pharmaceutical Group Co's average EBITDA Per Share Growth Rate was -46.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -4.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -8.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of China Resources Boya Bio-pharmaceutical Group Co was 59.60% per year. The lowest was -6.30% per year. And the median was 8.10% per year.

Competitive Comparison of China Resources Boya Bio-pharmaceutical Group Co's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, China Resources Boya Bio-pharmaceutical Group Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resources Boya Bio-pharmaceutical Group Co's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, China Resources Boya Bio-pharmaceutical Group Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where China Resources Boya Bio-pharmaceutical Group Co's 5-Year EBITDA Growth Rate falls into.

China Resources Boya Bio-pharmaceutical Group Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

China Resources Boya Bio-pharmaceutical Group Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000

Website

https://www.china-boya.com

China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Headlines

No Headlines